Please check your internet connection and try again.
# Megacv Duo (Amoxicillin / Clavulanate Potassium)
## Overview
Megacv Duo is a potentiated penicillin antibiotic combining amoxicillin (a beta-lactam) with clavulanate potassium (a beta-lactamase inhibitor). The addition of clavulanate extends the spectrum of activity against beta-lactamase-producing organisms.
## Primary Indications
* Community-acquired pneumonia
* Acute bacterial sinusitis
* Acute otitis media
* Skin and skin structure infections
* Urinary tract infections caused by susceptible organisms.
## Adult Dosing
* **Mild to Moderate Infections:** 875 mg amoxicillin / 125 mg clavulanate every 12 hours.
* **Severe or Respiratory Tract Infections:** 875 mg amoxicillin / 125 mg clavulanate every 8 hours.
* **Maximum:** Do not exceed 1750 mg of amoxicillin (as the 875 mg tablet) per 12-hour dosing period.
## Pediatric Dosing
* **General Dosing:** 25 mg/kg/day to 45 mg/kg/day of amoxicillin component, divided every 12 hours, depending on infection severity and organism susceptibility (specifically for *S. pneumoniae*).
* **Recurrent/Resistant Otitis Media:** High-dose (90 mg/kg/day amoxicillin) is often required; consult local guidelines as product concentrations vary widely.
* **Weight-Based Limits:** Do not exceed adult doses in pediatric patients.
## Dose Adjustments
* **Renal Impairment:** Reduce frequency for CrCl < 30 mL/min. Use is not recommended in patients with hemodialysis or severe renal impairment (CrCl < 30 mL/min) if the 875/125 mg tablet is used, as the ratio of clavulanate must be strictly controlled.
## Contraindications
* History of serious hypersensitivity (anaphylaxis) to any penicillin or cephalosporin.
* History of cholestatic jaundice or hepatic dysfunction associated with previous use of amoxicillin/clavulanate.
## Adverse Effects
* **Common:** Diarrhea, nausea, vomiting, abdominal pain.
* **Serious:** *Clostridioides difficile*-associated diarrhea, drug-induced hepatitis, cholestatic jaundice, severe skin reactions (e.g., SJS/TEN).
## Key Drug Interactions
* **Methotrexate:** Amoxicillin may reduce clearance, increasing toxicity risk.
* **Warfarin:** May increase INR and bleeding risk; monitor PT/INR closely.
* **Probenecid:** Decreases renal tubular secretion of amoxicillin, increasing serum levels.
* **Oral Contraceptives:** Potential for reduced efficacy (backup contraception recommended).
## Monitoring
* Renal and hepatic function (LFTs) during prolonged therapy.
* Monitor for signs of hypersensitivity and severe diarrhea (*C. difficile*).
## Clinical Pearls
* **Administration:** Take with food to reduce GI upset and optimize absorption.
* **Clavulanate Ratio:** Be aware that not all dosage strengths are interchangeable due to the clavulanate component. Ensure the correct formulation is selected to avoid sub-therapeutic amoxicillin dosing or excess clavulanate intake.
* **Local Resistance:** Always consult local antibiograms, as resistance, especially in *S. pneumoniae* and *E. coli*, varies by region.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical practice guidelines and local formulary protocols change frequently. Always verify current prescribing information, dosage, and patient-specific contraindications against official product labeling or local infectious disease institutional guidelines before prescribing or administering medication.
